<!DOCTYPE html>
<html lang="en">
<head>        <meta charset="utf-8">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">    <link
        rel="stylesheet"
        href="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/css/bootstrap.min.css"
        integrity="sha384-Gn5384xqQ1aoWXA+058RXPxPg6fy4IWvTNh0E263XmFcJlSAwiGgFAW/dAiS6JXm"
        crossorigin="anonymous"
    />
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/c3/0.6.12/c3.min.css"/>
    <style>
        h2 {
            margin-top: 35px;
        }

        html, body {
            height: 100%;
        }

        body {
            display: flex;
            flex-flow: column;
        }

        .footer {
            margin-top: auto;
            padding-top: 1em;
            background-color: #f5f5f5;
        }
    </style>    <title>KAMIKUBO_MYELOID_MN1_NETWORK</title></head>

<body>
<nav class="navbar navbar-expand-lg navbar-light bg-light">
    <span class="navbar-brand">
        Molecular Signatures Database
    </span>
</nav>

<div class="container" style="margin-top: 50px; margin-bottom: 50px">
<div class="card">
        <div class="card-header">
            KAMIKUBO_MYELOID_MN1_NETWORK
        </div>
        <div class="card-body">
                <p>Dominant RUNX1 inhibition has been proposed as a common pathway for CBF leukemia. CBF beta-SMMHC, a fusion protein in human acute myeloid leukemia (AML), dominantly inhibits RUNX1 largely through its RUNX1 high-affinity binding domain (HABD). However, the type I CBF beta-SMMHC fusion in AML patients lacks HABD. Here, we report that the type I CBF beta-SMMHC protein binds RUNX1 inefficiently. Knockin mice expressing CBF beta-SMMHC with a HABD deletion developed leukemia quickly, even though hematopoietic defects associated with Runx1-inhibition were partially rescued. A larger pool of leukemia-initiating cells, increased MN1 expression, and retention of RUNX1 phosphorylation are potential mechanisms for accelerated leukemia development in these mice. Our data suggest that RUNX1 dominant inhibition may not be a critical step for leukemogenesis by CBF beta-SMMHC.</p>
            <dl>
                <dt>Local Unique Identifier</dt>
                <dd><a href="https://bioregistry.io/msigdb:M2093">M2093</a>
                </dd>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            in taxon (<code>RO:0002162</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/NCBITaxon:10090">NCBITaxon:10090</a></li>
                        </ol>
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            has part (<code>BFO:0000051</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/ncbigene:6925">ncbigene:6925</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:7046">ncbigene:7046</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:84105">ncbigene:84105</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4300">ncbigene:4300</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10787">ncbigene:10787</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:7171">ncbigene:7171</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:116064">ncbigene:116064</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6002">ncbigene:6002</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8674">ncbigene:8674</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5965">ncbigene:5965</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4330">ncbigene:4330</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10634">ncbigene:10634</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5873">ncbigene:5873</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10857">ncbigene:10857</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:57509">ncbigene:57509</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8895">ncbigene:8895</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10981">ncbigene:10981</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6446">ncbigene:6446</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1397">ncbigene:1397</a></li>
                        </ol>
                    </dt>
            </dl>
            <span class="badge badge-warning">Term generation via PyOBO is currently under construction</span>
            <blockquote>
                Term(reference=Reference(prefix=&#39;msigdb&#39;, identifier=&#39;M2093&#39;, name=&#39;KAMIKUBO_MYELOID_MN1_NETWORK&#39;), definition=&#39;Dominant RUNX1 inhibition has been proposed as a common pathway for CBF leukemia. CBF beta-SMMHC, a fusion protein in human acute myeloid leukemia (AML), dominantly inhibits RUNX1 largely through its RUNX1 high-affinity binding domain (HABD). However, the type I CBF beta-SMMHC fusion in AML patients lacks HABD. Here, we report that the type I CBF beta-SMMHC protein binds RUNX1 inefficiently. Knockin mice expressing CBF beta-SMMHC with a HABD deletion developed leukemia quickly, even though hematopoietic defects associated with Runx1-inhibition were partially rescued. A larger pool of leukemia-initiating cells, increased MN1 expression, and retention of RUNX1 phosphorylation are potential mechanisms for accelerated leukemia development in these mice. Our data suggest that RUNX1 dominant inhibition may not be a critical step for leukemogenesis by CBF beta-SMMHC.&#39;, provenance=[Reference(prefix=&#39;pubmed&#39;, identifier=&#39;20478528&#39;, name=None)], relationships=defaultdict(&lt;class &#39;list&#39;&gt;, {TypeDef(reference=Reference(prefix=&#39;RO&#39;, identifier=&#39;0002162&#39;, name=&#39;in taxon&#39;), comment=None, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=None, holds_over_chain=None): [Reference(prefix=&#39;NCBITaxon&#39;, identifier=&#39;10090&#39;, name=&#39;Mus musculus&#39;)], TypeDef(reference=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000051&#39;, name=&#39;has part&#39;), comment=&#39;Inverse of part_of&#39;, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000050&#39;, name=&#39;part of&#39;), holds_over_chain=None): [Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6925&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;7046&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;84105&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4300&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10787&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;7171&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;116064&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6002&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8674&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5965&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4330&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10634&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5873&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10857&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;57509&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8895&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10981&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6446&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1397&#39;, name=None)]}), properties=defaultdict(&lt;class &#39;list&#39;&gt;, {&#39;category_code&#39;: [&#39;C2&#39;], &#39;sub_category_code&#39;: [&#39;CGP&#39;], &#39;contributor&#39;: [&#39;Arthur Liberzon&#39;], &#39;exact_source&#39;: [&#39;Table 2S&#39;]}), parents=[], synonyms=[], xrefs=[], alt_ids=[], namespace=None, is_obsolete=False)
            </blockquote>
        </div>
    </div></div>

<footer class="footer">
    <p class="small text-center text-muted">
        Generated with PyOBO
    </p>
</footer>

<script src="https://code.jquery.com/jquery-3.2.1.slim.min.js"
        integrity="sha384-KJ3o2DKtIkvYIK3UENzmM7KCkRr/rE9/Qpg6aAZGJwFDMVNA/GpGFF93hXpG5KkN"
        crossorigin="anonymous"></script>
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/js/bootstrap.min.js"
        integrity="sha384-JZR6Spejh4U02d8jOt6vLEHfe/JQGiRRSQQxSfFWpi1MquVdAyjUar5+76PVCmYl"
        crossorigin="anonymous"></script></body>
</html>